Amyloidosis: open trials in France

• NCT06128629

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  Trial Treatment · Phase 3 · Intellia Therapeutics

  Assistance Publique Hopitaux De Paris, Creteil · Centre Hospitalier Regional De Marseille, Marseille · Assistance Publique Hopitaux De Paris, Paris Cedex 18 · Centre Hospitalier Universitaire de Rennes, Rennes · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9

  Registry updated 2026-11-04

• NCT06978660

  Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis

  Research · Idoven 1903 S.L.

  Centre Hospitalier Universitaire de Toulouse, Toulouse

  Registry updated 2026-11-04

• NCT05652335

  A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

  Trial Treatment · Phase 1 · Janssen Research & Development, LLC

  Centre Hospitalier Universitaire de Nantes, Nantes · Centre Hospitalier Lyon-Sud, Pierre-Bénite · Centre Hospitalier Universitaire de Rennes, Rennes · Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse

  Registry updated 2026-11-03

• NCT06679946

  A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Trial Treatment · Phase 3 · Alnylam Pharmaceuticals

  Créteil · Marseille · Paris · Rennes · Toulouse

  Registry updated 2026-10-21

• NCT07207811

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  Centre Hospitalier Universitaire d'Amiens Picardie Site Sud, Amiens · Hospices Civils de Lyon (HCL) - Hopital Louis Pradel, Bron · Centre Hospital Regional Et Universitaire De Tours (Chru Tours) - Houpital Trousseau, Chambray-lès-Tours · Hospital Henri Mondor, Créteil · CHU de Dijon-Hôpital du Bocage, Dijon · Centre Hospitalier Departemental Vendee (CHD) - L'Hopital de la Roche-sur-Yon (CHD Les Oudairies), La Roche-sur-Yon · Centre Hospitalier Universitaire de Grenoble (CHUG) Hopital Nord, La Tronche · Assistance Publique Hopitaux de Marseille (AP-HM) - Hopital de la Timone, Marseille · Hospital Center Annecy Genevois-Centre Hospitalier de la Region d'Annecy CHRA, Metz-Tessy · Centre Hospitalier Regional Universitaire (CHRU) Montpellier Arnaud de Villeneuve, Montpellier · CHU de Nantes - Hôpital Laennec, Nantes · Centre Hospitalier Universitaire de Nice - Hopital Pasteur, Nice · Hôpital Bichat - Claude-Bernard, Paris · Groupement Hospitalier Universitaire Ouest - Hopital Europeen Georges-Pompidou (HEGP), Paris · Centre Hospitalier Universitaire de Bordeaux - Hopital Haut Leveque, Pessac · Centre Hospitalier Universitaire de Poitiers La Miletrie, Poitiers · Centre Hospitalier Universitaire (CHU) de Rennes, Rennes · Centre Hospitalier de Toulon - Hopital Sainte-Musse, Toulon · Centre Hospitalier Universitaire (CHU) de Toulouse - Hopital Rangueil, Toulouse · Private Hospital Medipole, Villeurbanne

  Registry updated 2026-10-21

• NCT07052903

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Trial Treatment · Phase 3 · Alnylam Pharmaceuticals

  Centre Hospitalier Regional Universitaire De Tours, Chambray Les Tours · Assistance Publique Hopitaux De Paris, Creteil Cedex · Centre Hospitalier Universitaire de Dijon, Dijon · CHU De Martinique, Fort De France Cedex · Centre Hospitalier Universitaire Grenoble Alpes, Grenoble Cedex 9 · Centre Hospitalier Regional De Marseille, Marseille · Centre Hospitalier Universitaire De Montpellier, Montpellier Cedex 5 · Assistance Publique Hopitaux de Paris, Paris · Assistance Publique Hopitaux De Paris, Paris Cedex 18 · Centre Hospitalier Universitaire de Bordeaux, Pessac · Centre Hospitalier Universitaire Reims, Reims Cedex · Centre Hospitalier Universitaire De Rennes, Rennes Cedex 9 · Centre Hospitalier Universitaire Rouen, Rouen Cedex · Centre Hospitalier Universitaire de Nantes, Saint-Herblain · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9

  Registry updated 2026-10-20

• NCT04561518

  ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

  Research · Alnylam Pharmaceuticals

  Bordeaux · Bron · Créteil · Le Kremlin-Bicêtre · Marseille

  Registry updated 2026-10-13

• NCT05040373

  Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

  Research · Alnylam Pharmaceuticals

  Nantes

  Registry updated 2026-10-08

• NCT07223203

  TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  Trial Treatment · Phase 3 · Alnylam Pharmaceuticals

  Assistance Publique Hopitaux De Paris, Creteil Cedex · Bicetre Hospital, Le Kremlin Bicetre Cedex · Centre Hospitalier Regional De Marseille, Marseille

  Registry updated 2026-10-08

• NCT07494942

  Impact of a Cardiac Rehabilitation Program on Patients With Cardiac Amyloidosis

  Trial Treatment · University Hospital, Montpellier

  KRIEF, Montpellier

  Registry updated 2026-10-08

• NCT07648303

  Prevalence of Cardiac Thrombi in Cardiac Amyloidosis

  Trial Treatment · Centre Hospitalier Universitaire Dijon

  Chu Dijon Bourogne, Dijon

  Registry updated 2026-09-17

• NCT07549841

  Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis

  Trial Treatment · Phase 2 · Nantes University Hospital

  Centre Hospitalier Universitaire De Nantes, Nantes Cedex 1

  Registry updated 2026-09-14

• NCT04849754

  Analysis of the Evolution of SUVmax by Quantitative Analysis Method of Bisphosphonate Scintigraphy

  Trial Treatment · GCS Ramsay Santé pour l'Enseignement et la Recherche

  Hôpital Privé Le Bois, Lille

  Registry updated 2026-08-20

• NCT07116473

  To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

  Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company

  Pellegrin Hospital, Bordeaux · AP-HP Hopital Henri Mondor, Créteil · CHU De Martinique, Fort De France Cedex · Bicetre Hospital, Le Kremlin Bicetre Cedex · CHU de Rennes, Rennes · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9

  Registry updated 2026-08-11

• NCT06563895

  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company

  Pellegrin Hospital, Bordeaux · Hôpital Henri Mondor, 1 rue Gustave Eiffel,, Créteil · CHU De Martinique, Fort De France Cedex · Bicetre Hospital, Le Kremlin Bicetre Cedex · Centre Hospitalier Universitaire de Rennes, Rennes · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9

  Registry updated 2026-08-04

• NCT05697861

  Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001

  Research · Phase 2/3 · Intellia Therapeutics

  Assistance Publique Hopitaux De Paris, Le Kremlin-Bicetre

  Registry updated 2026-08-03

• NCT07721350

  Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System

  Trial Treatment · Hospices Civils de Lyon

  Hopital Lyon Sud, Pierre-Bénite

  Registry updated 2026-07-23

• NCT06971848

  Evaluation of Skin Tests in Biotherapy Allergies

  Trial Treatment · University Hospital, Angers

  CHU Angers, Angers

  Registry updated 2026-06-18

• NCT07644325

  Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament Biopsy

  Trial Treatment · Clinique Saint Jean, France

  Clinique St Jean Sud de france, Montpellier

  Registry updated 2026-06-12

• NCT04636684

  Prevalence and Significance of ATTR Aortic Valve Amyloidosis in Degenerative Aortic Stenosis

  Trial Treatment · University Hospital, Toulouse

  university hospital center Toulouse, Toulouse

  Registry updated 2026-06-01

• NCT06158854

  A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

  Trial Treatment · Phase 1/2 · AbbVie

  Centre Hospitalier Et Universitaire De Limoges, Limoges Cedex 1 · Centre Hospitalier Universitaire De Toulouse, Toulouse Cedex 9

  Registry updated 2026-05-13

• NCT06427304

  Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

  Research · Gérond'if

  Chu Amiens Picardie, Amiens · CHU Angers, Angers · CHU Bordeaux, Bordeaux · Ambroise Paré Hospital, Boulogne-Billancourt · Centre Hospitalier de Carcassonne, Carcassonne · Centre Hospitalier Intercommunal de Castres Mazamet, Castres · CHU Trousseau-Tours, Chambray-lès-Tours · CHU Dijon, Dijon · CHU Grenoble Alpes, Grenoble · Corentin Celton Hospital, Issy-les-Moulineaux · Charles Foix Hospital, Ivry-sur-Seine · CHU Lille, Lille · Emile Roux Hospital, Limeil-Brévannes · CHU Limoges, Limoges · Chu Lyon, Lyon · CHU Marseille, Marseille · GH Sud Ile-de-France, Melun · Clinique du Millénaire-Montpellier, Montpellier · CHU Montpellier, Montpellier · CHRU Nancy, Nancy · CHU Nantes, Nantes · CHU Nice, Nice · Hôpital Privé Gériatrique LES SOURCES-Nice, Nice · CHU Orléans, Orléans · Saint Joseph Hospital, Paris · Bretonneau Hospital, Paris · Europeen Georges Pompidou Hospital, Paris · Geriatric Department, Broca Hospital, Paris · Lariboisière Hospital, Paris · CHU Poitiers, Poitiers · CHU Rennes, Rennes · CHU Rouen, Charles Nicole hospital, Rouen · CHU Toulouse, Toulouse · CHRU Tours-Bretonneau Hospital, Tours · Clinique Saint Joseph Trelaze, Trélazé · Médipôle Hôpital Mutualiste Villeurbanne, Villeurbanne

  Registry updated 2026-04-20

• NCT05667493

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  Trial Treatment · Phase 3 · Ionis Pharmaceuticals, Inc.

  Hôpitaux Universitaires Henri Mondor, Créteil · Centre Hospitalier Départemental Vendée, La Roche-sur-Yon · Hopital de la Timone, Marseille · Centre Hospitalier Universitaire De Nantes - Hôpital Nord Laennec, Nantes · Hopital Haut-Leveque, Pessac · Hopital Rangueil, Toulouse

  Registry updated 2026-04-17

• 2024-519812-15-00

  ETCABio - Evaluation of Skin Tests in Biotherapy Allergies

  Trial Treatment · Phase 4 · Centre Hospitalier Universitaire D'Angers

  Centre Hospitalier Universitaire D'Angers, Angers

  Registry updated 2026-03-19

• NCT06197165

  Amylo-Shiatsu-Acute-Chronic: Effects of Shiatsu on Symptoms and Quality of Life of Amyloidosis Patients

  Trial Treatment · Assistance Publique - Hôpitaux de Paris

  Assistance Publique - Hopitaux de Paris - CHU Henri Mondor, Créteil

  Registry updated 2026-01-15

All Amyloidosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error